section name header

Basics

Description

General

  • Pneumonectomy describes the complete removal of the lung and can be performed for ipsilateral lymph node metastasis or when a lobectomy and its modifications are not sufficient to remove diseased tissue.
  • for open procedures (thoracotomy), exposure and dissection involves either rib spreading or removal of a portion of the rib. The pulmonary artery and veins are identified and stapled first, followed by the main bronchus; removal of the lung from the chest cavity occurs subsequently. An extrapleural pneumonectomy requires a more extensive resection of lymph nodes, pericardium, diaphragm, parietal pleura, and the chest wall.
  • The procedure may also be performed thoracoscopically (VATS). The smaller incision and reduced surgical stress (inflammatory mediators) may decrease postoperative pain and pulmonary dysfunction.

Position

  • Lateral decubitus with the operative side up.
  • A bean bag and axillary roll are often utilized.

Incision

  • Posterior-lateral incision usually at the fifth or sixth intercostal space.
  • Median sternotomy approach has been described but is rarely performed today.

Approximate Time

~2–3 hours

EBL Expected

<500 mL; re-do or extrapleural pneumonectomies can be significantly higher

Hospital Stay

An average of 5–12 days

Special Equipment for Surgery

Arm boards and arm rest for lateral positioning

Epidemiology

Incidence

Most commonly performed for lung carcinoma

Prevalence

The prevalence of lung cancer is second to that of prostate cancer in men and breast cancer in women.

Morbidity

  • Postoperative pulmonary complications range from 11 to 49% (1) [B].
  • Right pneumonectomy is associated with cardiac herniation.
  • Age > 65 years, right-sided procedures, and dysrhythmias were associated with an increased risk of a major complication (p < 0.05) (2) [B].
  • Dysrhythmias increased the median length of stay from 8 to 11 days (p < 0.05). Age > 65 years, intrapericardial or extrapleural pneumonectomy, right-sided procedure, and any major complication are factors associated with an increased risk of dysrhythmias (p < 0.05) (2) [B].
  • Others: Pulmonary embolism, myocardial infarction (MI), bronchopleural fistulas, chylothorax, subcutaneous emphysema, phrenic and recurrent laryngeal nerve injury.

Mortality

  • Overall 30-day mortality ranges from 5–13% (5) [B].
  • Increased with low predicted postoperative FEV1 (ppo-FEV1), high perfusion fraction of the resected lung (3) [B], and postoperative acute lung injury (30–50%) (4) [B].
Anesthetic GOALS/GUIDING Principles

Diagnosis

Symptoms

Dyspnea, cough, hemoptysis

History

  • Extensive evaluation of pulmonary disease and cardiac status; exercise tolerance, cigarette smoking
  • Myasthenic syndrome (Eaton–Lambert)

Signs/Physical Exam

  • Cyanosis, clubbing
  • Auscultation: Crackles, wheezes, distant sounds.
  • Pulmonary hypertension: Split or increased second sound
  • Heart failure: Peripheral edema, jugular venous distention, hepatomegaly
Medications
Diagnostic Tests & Interpretation

Labs/Studies

  • EKG
    • COPD: Right atrial and ventricular hypertrophy, low voltage QRS, and poor R wave progression across the precordial leads
    • Cor pulmonale: Enlarged P waves in lead II.
  • Arterial blood gas: Baseline hypoxia or CO2 retention
  • Imaging: Chest x-ray (CXR), CT scan, MRI to identify airway anatomy, masses, obstruction to flow and narrowing of airway, lung lesions/disease, lung hyperinflation, effusions, abscesses and hematomas
  • Pulmonary function tests: Performed to establish a baseline, to determine the ability to tolerate lung resection, and to risk stratify.
  • Split-lung function tests: Predicts the function of the lung tissue that will remain after resection
CONCOMITANT ORGAN DYSFUNCTION

Treatment

PREOPERATIVE PREPARATION

Premedications

  • Minimize use of benzodiazepines and narcotics (may worsen hypercarbia). Benzodiazepines may contribute to postoperative delirium, especially in elderly patients.
  • Nebulizers: Beta agonists and anticholinergics.

Antibiotics/Common Organisms

Third generation cephalosporin for skin organisms

INTRAOPERATIVE CARE

Choice of Anesthesia

General anesthesia with thoracic epidural placement or ipsilateral paravertebral blocks with catheter placement for continuous infusion (6,7) [B]

Monitors

  • Standard ASA monitors
  • Arterial line
  • Central line for CVP tracing and SvO2 monitoring
  • TEE

Induction/Airway Management

  • Induction agent (often based on cardiac status) along with IV lidocaine, narcotics, and muscle relaxation are most commonly used. Introduction of volatile agent during bag mask ventilation will bronchodilate prior to laryngoscopy and intubation.
  • Double lumen tube (DLT), bronchial blocker, or main-stemmed single lumen tube. A fiberoptic scope is used to confirm proper placement.

Maintenance

  • Ventilation
    • During OLV, implement an FiO2 of 1.0, low tidal volumes 5–6 mL/kg, and limit peak and plateau pressures to <35 and 25 cm H2O, respectively (8) [A].
    • In the event of hypoxia, reassess tube position with FOB, if surgically possible proceed with brief manual bilateral lung ventilation, if not possible implement CPAP to the nondependent lung, followed by PEEP to the dependent lung, and consider pulmonary artery clamping.
    • ABGs should be performed intermittently or for intraoperative events to assess PaO2, PaCO2
  • Fluids: A fluid restrictive technique has been shown to decrease the risk of ALI; however, it must be balanced with preserving renal funciton. It may be necessary to implement inotropes and vasoactive drugs to maintain adequate perfusion pressure and hemodynamic stability. Blood products should be administered in accordance with blood loss.
  • Renal: Maintain adequate perfusion pressures and a urine output of 0.5 mL/kg/hr.
  • Hemodynamics: Monitor cardiac function through TEE, CVP for right ventricle straining and failure, especially after pulmonary artery occlusion.
  • Analgesia: IV narcotics should be limited if a regional epidural catheter has been placed. Medication administration through the epidural catheter is usually initiated toward the end of the procedure once the chance of acute blood loss and unexpected hypotension is low.

Extubation/Emergence

  • Following repositioning, the heart can herniate into the empty right chest causing severe hemodynamic changes. The patient should be immediately repositioned in the left lateral decubitus and the surgeon should evaluate. A CXR can reveal if there is rapid filling of the empty chest and if drainage is necessary to balance the mediastinum.
  • If the patient is left intubated, the DLT needs to be exchanged for a single lumen. Sedation with propofol, dexmedetomidine, midazolam, or fentanyl should be started for transport to the ICU.

Follow-Up

Bed Acuity

ICU for a few days, followed by a step-down unit or floor.

Analgesia
Complications
Prognosis

References

  1. Algar F , Alvarez A , Salvatierra A , et al. Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg. 2003;23:201208.
  2. Harpole DH , Liptay MJ , DeCamp MM Jr, et al. Prospective analysis of pneumonectomy: Risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996;61:977982.
  3. Kim JB , Lee SW , Park SI , et al. Risk factor analysis for postoperative acute respiratory distress syndrome and early mortality after pneumonectomy: The predictive value of preoperative lung perfusion distribution. J Thorac Cardiovasc Surg. 2010;140:2631.
  4. Licker M , de Perrot M , Spiliopoulos A , et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003;97:15581565.
  5. Ramnath N , Demmy TL , Antun A , et al. Pneumonectomy for bronchogenic carcinoma: Analysis of factors predicting survival. Ann Thorac Surg. 2007;83(5):18311836.
  6. Richardson J , Sabanathan S , Jones J , et al. A prospective, randomized comparison of preoperative and continuous balanced epidural or paravertebral bupivacaine on post-thoracotomy pain, pulmonary function and stress responses. Br J Anaesth. 1999;83(3):387392.
  7. Powell ES , Cook D , Pearce AC , et al. A prospective, multicentre, observational cohort study of analgesia and outcome after pneumonectomy. Br J Anaesth. 2011;106(3):364370.
  8. Schilling T , Kozian A , Huth C , et al. The pulmonary immune effect of mechanical ventilation in patients undergoing thoracic surgery. Anesth Analg. 2005;101:957965.
  9. Smetanta GW. Preoperative pulmonary evaluation: Identifying and reducing risks for pulmonary complications. Cleve Clin J Med. 2006;73(Suppl 1):S36S41.
  10. Slinger P , et al. Preoperative evaluation of the thoracic surgery patient. Semin Anesth. 2002;21:168.
  11. Nakahara K , Ohno K , Hashimoto J , et al. Prediction of postoperative respiratory failure in patients undergoing lung resection for cancer. Ann Thorac Surg. 1988;46:549552.

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Clinical Pearls

Author(s)

Daniel Castillo , MD

Sascha Beutler , MD, PhD